2024 SomaScan® Australia Research Grant Award
Each winner will receive high-plex proteomic data of 40 samples to accelerate their research.
Overview
We are pleased to introduce the SomaScan Research Grant Award for Australian researchers. Recipients will receive high-plex proteomic data for 40 samples of human plasma or serum. Analysis will be performed using the SomaScan Assay 11,000 protein menu. Each winning award is valued at USD $38,000.
Program details
The goal of this program is to assist researchers in Australia in generating pilot data that can be used to support their future grant applications, and to promote use of the SomaScan assay as an essential tool for producing high quality proteomic data. Applicants’ proposals will be reviewed within 4 weeks of the submission close date (31 October 2024).
Applicants should write a short proposal of 500 words or less, outlining a pilot research project including the use of the SomaScan assay.
A committee of Standard BioTools staff will review and select the winning applicant based on the following criteria:
- The overall application completeness.
- Did the applicant have an original proposal with clear goals and outcomes.
- Does the proposal provide a clear approach and design to match the goals and outcomes.
- Explanation of how the protein data and analysis are intended to be used.
- What are the next steps the researcher intends to take with this additional knowledge.
- How does SomaScan data increase insight into health and disease for their given focus area.
Winners
Two (2) winners will be selected and awarded the opportunity to process forty (40) samples on the SomaScan assay, together with upstream and downstream support from Standard BioTools (including discussions with Technical support to validate sample type and discuss limitations, and with the project management team to work through sample prep/shipping and downstream bioinformatic support), excluding shipment costs to the USA. The samples for this program must be banked, frozen & ready to go!
If applicants have any questions about sample submission requirements, they should email Standard BioTools at [email protected]
Application timelines
Grant announced by Standard BioTools and advertised via the Standard BioTools database to eligible customers in Australia.
Announced |
2 September 2024 |
Open |
2 September 2024 |
Submission close | The submission window has closed |
Winner announced |
30 November 2024 |
Samples submitted for processing |
30 January 2025 or earlier |
Data from SomaScan Assay delivered |
30 March 2025 |
Eligibility criteria
- The grant program terms and conditions apply.
- The grant is only open to researchers who are based in Australia, at an institution or group where they perform the research.
- Research teams who already use the SomaScan Assay are not eligible to apply.
- All submissions must be in English and comply with the criteria outlined in this guide.
- The samples processed on the SomaScan Assay need to be available and meet certain criteria (see the Handling and Processing Guide for more information).
- Greater consideration will be given to pilot studies that are creative, bring new insight to health and disease, and have potential to lead to longer-term studies.
- For questions about your eligibility or the study you have proposed, please email Standard BioTools at [email protected].
- Only one application per person is allowed.
The submission window for this grant has closed
Research grant conditions
- The two successful applicants will receive SomaScan 11K Assay data for each of their 40 samples, as well as time with Technical Support to validate sample type and discuss limitations, and access to a project management team to discuss sample prep/shipping and downstream bioinformatic support.
- Samples will be run on the SomaScan Assay by Standard BioTools at their facility in Boulder, Colorado.
- The application submission deadline is 30 October 2024. Any submission made after this date will not be accepted.
- Successful applicants consent to their name and organization being used for promotional purposes under this grant program.
- The winner will be announced by email and on social media (Facebook, X, LinkedIn), and will be encouraged to present their research in Standard BioTools marketing activities.
- For questions about your eligibility or to ask questions about the study you have proposed, please email Standard BioTools at [email protected].
- The grant is for research purposes only and is not to be used for commercial or clinical purposes.
- The applications will be reviewed by a Standard BioTools committee, and a winner decided by the same.
- The decision from Standard BioTools is final on study feasibility.
- All entrants agree to be contacted by Standard BioTools for marketing purposes.
- Special grant terms and conditions apply.
Sample submission
- The grant winners will provide 40 samples to be run on the SomaScan 11K Assay with the output product being data showing signaling for 11,000 protein targets.
- Samples must be human plasma or serum. Other sample types may be considered after consultation.
- Samples submitted must be 130 μL volume and have been prepared according to the Standard BioTools Handling and Processing Guide. Recording, delivery and labeling will be discussed with the winners.
- Sample submissions, including any associated documentation, cannot include any personal or health information on human subjects. Awardees agree to comply with all applicable laws and regulations with their grant submission and, if awarded, their sample submissions.
- Shipment of samples must be at the awardee’s expense via suitable cold chain courier with dry ice top-up, and preferably tracking.